iptacopan
Showing 1 - 9 of 9
Atypical Hemolytic Uremic Syndrome Trial (Iptacopan)
Not yet recruiting
- Atypical Hemolytic Uremic Syndrome
- Iptacopan
- (no location specified)
Jun 29, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial (Iptacopan)
Not yet recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- Iptacopan
- (no location specified)
Nov 18, 2022
IC-MPGN Trial (Placebo, iptacopan)
Not yet recruiting
- IC-MPGN
- Placebo
- iptacopan
- (no location specified)
Feb 23, 2023
Hepatic Impairment Trial in San Antonio (Iptacopan)
Completed
- Hepatic Impairment
- Iptacopan
-
San Antonio, TexasNovartis Investigative Site
Sep 20, 2022
C3 Glomerulopathy (C3G) Trial (Iptacopan)
Available
- C3 Glomerulopathy (C3G)
- Iptacopan
- (no location specified)
Jan 24, 2023
Immune Thrombocytopenia (ITP), Cold Agglutinin Disease (CAD) Trial in Worldwide (Iptacopan)
Recruiting
- Immune Thrombocytopenia (ITP)
- Cold Agglutinin Disease (CAD)
- Iptacopan
-
Boston, Massachusetts
- +11 more
Dec 15, 2022
Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Iptacopan)
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
- Iptacopan
-
Brno - Bohunice, Czechia
- +30 more
Jul 29, 2022
Atypical Hemolytic Uremic Syndrome Trial in Worldwide (Iptacopan)
Recruiting
- Atypical Hemolytic Uremic Syndrome
- Iptacopan
-
Torrance, California
- +19 more
Aug 10, 2022
C3G Trial in Worldwide (Placebo, iptacopan)
Recruiting
- C3G
- Placebo
- iptacopan
-
Aurora, Colorado
- +60 more
Nov 23, 2022